Table 3.

Adverse events

Classification	No. of patients	No. of episodes	Severity, grade*	No. of related episodes†	No. of unrelated episodes
Serious	11	22	2-5	0	22
Nonserious‡	75	100	1-3	53	47
Emesis	12	19	1-2	11	8
Nausea	10	18	1-2	17	1
Increased AST/ALT level	10	10	1-3	6	4
Anemia	8	9	1-3	5	4
Edema	4	7	1-3	7	0
Diarrhea	5	5	1-3	2	3
Thrombocytopenia	2	3	2-3	2	1
Neutropenia	2	2	2-3	2	0
Anorexia	1	1	2	1	0

^*Common Toxicity Criteria (CTC) version 3.0.

^†Related events include possibly, probably, or definitely related events and unrelated events include those unlikely to be or definitely not related.

^‡Shown are those categories of nonserious adverse events that included at least one episode with probable or possible relationship to imatinib therapy.